1 not yet recruiting, 1 terminated. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Anti-Xa Activity: new trials by email Literature Review of Anti-Xa Activity trials Research Report on Anti-Xa Activity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The OAT Trail: The Obesity Anti-Coagulation Thromboprophylaxis Trial. Anti-Xa Activity Monitoring, Tinzaparin (Leo), enoxaparin - Bariatric Surgery, Anti-Xa Activity | Not applicable | Not yet recruiting | University College Dublin | 180 | 2026-08-01 | 2026-05-18 |
| A Pilot Study Investigating Apixaban and Dexamethasone InterAction in Multiple Myeloma apixaban - Anti-Xa Activity | Phase 2 | Terminated | University of British Columbia | 2 | 2016-08-09 | 2021-08-23 |
Obesity (1) · Overweight (1) · Venous Thromboembolism (1)
Body Weight (1) · Cardiovascular Diseases (1) · Embolism and Thrombosis (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Overnutrition (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Thromboembolism (1) · Vascular Diseases (1)
Enoxaparin (1) · Tinzaparin (1) · apixaban (1)
University College Dublin (1) · University of British Columbia (1)
Canada (1) · Ireland (1)
Agnes YY Lee, MD MSc FRCPC (1) · Helen M Heneghan, PhD, FRCSI (1)
PMID 11867132, PMID 14987333, PMID 18086925, PMID 19036065, PMID 19458109, PMID 20332509, PMID 20622663, PMID 22315264, PMID 23303884, PMID 24141714, PMID 26868660, PMID 28930514, PMID 30121858, PMID 32202076, PMID 34896011